Dr. Alan Baer graduated from the Johns Hopkins University School of Medicine in 1978 and completed his post-graduate medical training in Internal Medicine and Rheumatology at the Johns Hopkins and Vanderbilt University Hospitals. He was a faculty member at the University at Buffalo, State University of New York, from 1986 to 2007, and served there as Chief of the Section of Rheumatology and Fellowship Program Director. He joined the faculty at Johns Hopkins in 2007 and is currently Professor of Medicine and Director of the Jerome L. Greene Sjogren's Syndrome Center. Since 2015, he has been an Investigator in the Sjogren's Syndrome Clinic at the National Institutes of Health. He was Chief of Rheumatology and Clinical Director of the Johns Hopkins University Rheumatology Practice at the Good Samaritan Hospital in Baltimore, Maryland from 2007 to 2014. Dr. Baer is currently engaged in a number of research studies in the area of Sjogren's syndrome, both at Johns Hopkins and in the NIH Sjogren's Syndrome Clinic. He was the principal investigator of the NIH subcontract to Johns Hopkins to conduct the Sjogren's International Registry (SICCA) and enrolled 300 patients into the registry. The SICCA registry has been a rich source of clinical data and biospecimens for research that Dr. Baer is conducting with colleagues at both Hopkins and the University of California-San Francisco. He is conducting a longitudinal observational study of patients with Sjogren's syndrome. Dr. Baer is rated as a Distinguished provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Arthritis, and Interstitial Keratitis.

Dr. Laura Cappelli is an Associate Professor of Medicine and Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include rheumatology and adverse effects from cancer immunotherapy. Dr. Cappelli earned her M.D. from Johns Hopkins. She completed her residency in internal medicine and performed a fellowship in rheumatology at the Johns Hopkins Hospital. She has a MHS in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Cappelli focuses on immune related adverse events due to cancer immunotherapy and all forms of inflammatory arthritis. She co-directs the Immune-related toxicity team which provides clinical, research and educational support for immune related adverse events. Her primary research interest is inflammatory arthritis due to immune checkpoint inhibitor therapy. She also studies rheumatoid arthritis. Dr. Cappelli is rated as a Distinguished provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Arthritis, Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, and Polymyalgia Rheumatica.

Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as an Advanced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy.

Dr. Maximilian Konig is an Assistant Professor of Medicine in the Division of Rheumatology and Director of the Cellular Therapy Program (Autoimmunity) in the Department of Medicine at the Johns Hopkins University School of Medicine. He received his medical degree from Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin (Germany) and completed his residency training in the Stanbury Physician-Scientist Pathway at Massachusetts General Hospital, Harvard Medical School. Dr. Konig concluded subspecialty training in Clinical and Molecular Rheumatology as well as Advanced Rheumatology at Johns Hopkins Hospital. His clinical interests lie in treating patients with systemic autoimmune diseases, including myositis, scleroderma, lupus, vasculitis, and inflammatory arthritis. Dr. Konig is rated as an Advanced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Systemic Lupus Erythematosus (SLE), and Periodontitis.

Dr. Uzma Haque is an Assistant Professor of Medicine at the Arthritis Center at The Hopkins Bayview Medical Center, and is actively engaged in clinical care to patients with general rheumatic and musculoskeletal disorders. Dr. Haque is rated as an Advanced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis.

Dr. Clifton Bingham is a Professor of Medicine, Director of the Johns Hopkins Arthritis Center, Director of the Center for Patient-Centered Outcomes Research in Rheumatology, Deputy Director for Research in the Division of Rheumatology, and Co-Director of the Rheumatic Diseases Research Core Center. He received his M.D. from Columbia University, where he also completed his Internal Medicine residency. He trained as a Fellow in both Rheumatology and in Allergy and Clinical Immunology at the Brigham and Women’s Hospital. Before coming to Hopkins in 2005, he was on faculty at NYU Hospital for Joint Diseases, where he founded a pioneering clinical and translational research center in rheumatology. He now directs the Johns Hopkins Arthritis Center, a group of 8 rheumatologists, 2 nurses, and a large clinical and research staff that sees more than 4500 patient visits each year, an integrates research with clinical care. His clinical interests are in the care of people living with Rheumatoid Arthritis (RA) and other forms of inflammatory arthritis. Dr. Bingham’s research experience has been diverse, and across the research continuum from bench to bedside. His early work focused on understanding the cytokine regulation of inflammatory mediator generation operative in rheumatologic and allergic diseases. He conducted prior translational research to better understand the role of initiating and amplifying pathways in RA, and has ongoing collaborations with several basic researchers to identify biomarkers for improved patient phenotyping and outcome prediction. Additional multidisciplinary clinical and translational work has focused on the role of periodontal disease and oral bacteria as triggers of RA. In the realm of clinical research, he has served as principal investigator and helped to design and analyze a number of NIH and industry-sponsored clinical trials of multiple agents in early to late phases of development for RA, psoriatic arthritis, and osteoarthritis. He has led several studies of the effects of biological and immunomodulatory therapies on responses to immunizations. A large amount of his current research is focused in the area of patient centered outcomes research, including patient reported outcome development, validation, and integration in clinical care. He serves as a member of the Executive Leadership Committee for the international Outcome Measures in Rheumatology (OMERACT) methodology group. He has authored more than 170 original research articles, reviews, and editorials, and 12 book chapters. He served as a Co-Editor for the journal of the American College of Rheumatology, Arthritis and Rheumatology, and as a reviewer for a number of rheumatology journals and national and international grant reviews. Dr. Bingham is rated as an Advanced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Rheumatoid Arthritis (RA), Psoriatic Arthritis, Psoriasis, and Ankylosing Spondylitis.

Andrea Fava is a Rheumatologist in Baltimore, Maryland. Dr. Fava is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc).

Dr. Antony Rosen was an Osler resident and rheumatology fellow at Johns Hopkins Hospital before joining the faculty at Johns Hopkins, where he was appointed a professor in 2002. He served as director of the Division of Rheumatology between 2002 and 2022, overseeing a substantial expansion in the fellowship program and building the faculty from 14 to 26, and has been the Vice Dean for Research since 2013. Dr. Rosen received his medical degree from the University of Cape Town in South Africa in 1984 with first-class honors. After completing his internship in medicine & surgery and a year of postdoctoral study in medical biochemistry, he joined Dr. Alan Aderem at the Rockefeller University to pursue postdoctoral studies in immunology and cellular biology. Dr. Rosen is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Dermatomyositis, Polymyositis, Scleroderma, and Systemic Sclerosis (SSc).

Dr. Allan Gelber is Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research. Dr. Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in Clinical Investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University and then undertook his fellowship training in rheumatology at Johns Hopkins. Dr. Gelber has had an active role as an Educator in the Rheumatic Diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001-2011. Thereafter, he shifted his primary educational focus from rheumatology fellows to medical students, and to internal medicine housestaff on the Bayview and Johns Hopkins campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to the 2nd year medical school class. Currently, Dr. Gelber serves as Thayer Firm Faculty Leader of the Osler Medical Training Program. and among the Aliki Scholars at Johns Hopkins Bayview Medical Center. Dr. Gelber chairs the M.D. Admissions Committee at the School of Medicine. Dr. Gelber is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Gout, Arthritis, Scleroderma, Knee Replacement, and Endoscopy.

Lanaya Smith is a Rheumatologist in Baltimore, Maryland. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Mixed Connective Tissue Disease, MASS Phenotype, IgG4-Related Disease, MAGIC Syndrome, and Tissue Biopsy. Dr. Smith is currently accepting new patients.

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE).

Dr. Philip Seo is an Associate Professor in the Division of Rheumatology. A graduate of Harvard College and the College of Physicians and Surgeons at Columbia University, Dr. Seo completed his Internal Medicine training as a member of the Osler Medical Service at the Johns Hopkins Hospital. Since then, he has worked at Johns Hopkins in several capacities, including as a hospitalist at Johns Hopkins Bayview Medical Center, and as an Assistant Chief of Service of the Department of Medicine at the Johns Hopkins Hospital, before joining the Division of Rheumatology. Dr. Seo is the Director of the Johns Hopkins Vasculitis Center and Director of the Johns Hopkins Rheumatology Fellowship Program. His clinical interests lie in the assessment and treatment of patients with systemic vasculitis, in particular, the ANCA-associated vasculitides, which include granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis. Dr. Seo is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Granulomatosis with Polyangiitis, Vasculitis, Microscopic Polyangiitis, Takayasu Arteritis, and Tissue Biopsy.

Dr. Grader-Beck is an Associate Professor of Clinical Medicine in the Rheumatology Division. Dr. Grader-Beck’s clinical expertise includes the diagnosis and treatment of Sjogren's syndrome as well as inflammatory arthritis. He has a specific interest in improving quality of patient care and clinical research using state of the art information technology. He is developing innovative ways in how clinicians and researchers can leverage electronic health record systems to deliver individualized patient care and precision medicine. Dr. Grader is rated as an Advanced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Interstitial Keratitis, and Dermatomyositis.

John Miller is a Rheumatologist in Baltimore, Maryland. Dr. Miller is rated as an Advanced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Microscopic Polyangiitis, Scleroderma, Rheumatoid Arthritis (RA), and Erythromelalgia.

Dr. Albayda is an Associate Professor of Medicine in the Division of Rheumatology. She is the Director of the Rheumatology Fellowship Program, as well as Director of the Musculoskeletal Ultrasound and Injection Clinic. Nationally, she is involved in MSK Ultrasound education and has expertise in arthritis and inflammatory myopathies. Her research focuses on imaging biomarkers in rheumatic diseases, developing muscle ultrasound, clinical phenotypes in myositis, as well as longitudinal care and therapeutics in inclusion body myositis. Dr. Albayda is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Dermatomyositis, Pallister-Killian Mosaic Syndrome, Temple Syndrome, and Inclusion Body Myositis.

Dr. Brit Adler is an Assistant Professor of Medicine in the Division of Rheumatology at Johns Hopkins University. She is building a career as a translational physician-scientist with a focus on Postural Orthostatic Tachycardia Syndrome (POTS) and infection-associated chronic illnesses. Her interest in this area emerged from her work in general rheumatology, where she frequently encountered patients with POTS, an often-overlooked and understudied condition. She is particularly interested in investigating the immune dysregulation underlying POTS, Long COVID, and Chronic Lyme Disease. By leveraging her prior experience in autoantibody discovery in rheumatic diseases, Dr. Adler aims to deepen our understanding of these conditions. In addition to her work in general rheumatology, Dr. Adler leads a dedicated POTS clinic and evaluates patients in the Hopkins Autonomic Lab, furthering her commitment to improving care for patients with autonomic disorders. She earned her medical degree from Case Western Reserve University in Cleveland, Ohio, and completed her residency in Internal Medicine at the Hospital of the University of Pennsylvania. Following this, she pursued a clinical and research fellowship in Rheumatology at Johns Hopkins. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Inclusion Body Myositis.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Dermatomyositis, Myositis, Scleroderma, and Polymyositis.

Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included granulomatosis with polyangiitis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. Dr. Hellmann is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). His top areas of expertise are Behcet Disease, Necrotizing Vasculitis, Takayasu Arteritis, and Juvenile Temporal Arteritis.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Experienced provider by MediFind in the treatment of Rheumatoid Arthritis (RA). Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.